Treatment of hepatitis C virus-related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment-Reference-Cited by-同舟云学术

Treatment of hepatitis C virus-related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment

Published:1999-06 Issue:6 Volume:29 Page:1870-1875
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Valla Dominique-Charles,Chevallier Michele,Marcellin Patrick,Payen Jean-Louis,Trepo Christian,Fonck Marianne,Bourliere Marc,Boucher Evelyne,Miguet Jean-Philippe,Parlier David,Lemonnier Catherine,Opolon Pierre

Publisher

Wiley

Subject

Hepatology

Reference30 articles.

1. Hepatitis C: The clinical spectrum of disease

2. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients

3. Hepatitis C: Somber views of natural history and optimistic views of interferon treatment?

4. Hepatitis C and hepatocellular carcinoma

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow;Biomarker Research;2022-09-14

2. Screening for Hepatitis C Virus Infection in Adolescents and Adults;JAMA;2020-03-10

3. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment;Cancer Medicine;2019-02-21

4. Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis;BMC Gastroenterology;2017-04-04

5. The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?;Expert Review of Anti-infective Therapy;2016-10-12